Accessibility Menu
 
IN8bio logo

IN8bio

(NASDAQ) INAB

Current Price$1.49
Market Cap$14.67M
Since IPO (2021)-100%
5 YearN/A
1 Year-63%
1 Month+6%

IN8bio Financials at a Glance

Market Cap

$14.67M

Revenue (TTM)

$0.00

Net Income (TTM)

$18.98M

EPS (TTM)

$-2.85

P/E Ratio

-0.52

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Price

$1.49

Volume

93

Open

$1.49

Previous Close

$1.49

Daily Range

$1.49 - $1.49

52-Week Range

$1.17 - $5.61

INAB News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About IN8bio

Industry

Biotechnology

Employees

18

CEO

William T. Ho, MBA

Headquarters

New York City, NY 10118, US

INAB Financials

Key Financial Metrics (TTM)

Gross Margin

0%

Operating Margin

0%

Net Income Margin

0%

Return on Equity

-104%

Return on Capital

-79%

Return on Assets

-72%

Earnings Yield

-1.92%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$14.67M

Shares Outstanding

9.85M

Volume

93

Avg. Volume

61.55K

Financials (TTM)

Gross Profit

$2.50M

Operating Income

$19.86M

EBITDA

$17.36M

Operating Cash Flow

$12.71M

Capital Expenditure

$0.00

Free Cash Flow

$12.71M

Cash & ST Invst.

$27.09M

Total Debt

$2.78M

IN8bio Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2026YOY CHG

Revenue

$0.00

N/A

Gross Profit

$500.00K

N/A

Gross Margin

0.00%

N/A

Market Cap

$14.67M

N/A

Market Cap/Employee

$815.12K

N/A

Employees

18

N/A

Net Income

$5.09M

+8.3%

EBITDA

$4.77M

+4.5%

Quarterly Fundamentals

Name
Q1 2026YOY CHG

Net Cash

$19.59M

+157.2%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$1.33M

-56.3%

Short Term Debt

$1.03M

-16.9%

Return on Assets

-72.26%

N/A

Return on Invested Capital

-79.46%

N/A

Free Cash Flow

$4.96M

-58.7%

Operating Cash Flow

$4.95M

-58.5%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
PHIOPhio Pharmaceuticals Corp.
$1.08+0.93%
KPRXKiora Pharmaceuticals, Inc.
$2.51+0.40%
APVOAptevo Therapeutics Inc.
$4.68-1.90%
RNAZTransCode Therapeutics, Inc.
$6.64+0.61%

Trending Stocks

Symbol / CompanyPricePrice Chg
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$14.27-0.05%
TET1 Energy Inc.
$6.62+0.17%
POETPoet Technologies
$14.27-0.11%
FFord Motor Company
$13.20-0.01%

Questions About INAB

What is the current price of IN8bio?

IN8bio is trading at $1.49 per share.

What is the 52-week range for IN8bio?

Over the past 52 weeks, IN8bio has traded between $1.17 and $5.61.

How much debt does IN8bio have?

As of the most recent reporting period, IN8bio reported total debt of $2.35M.

How much cash does IN8bio have on hand?

IN8bio reported $21.94M in cash and cash equivalents in its most recent financial results.

What is IN8bio’s dividend yield?

IN8bio does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.